City St. George’s researchers identified 9 genetic signatures and epigenetic changes driving lapatinib resistance in HER2-positive breast cancer.
Ateequllah Hayat, PhD
Advertisement
Ateequllah Hayat, PhD, is an academic scientist with industry experience and a lecturer in drug development at City St. George, University of London.
Articles by Ateequllah Hayat, PhD
Ateequllah Hayat, PhD, discusses epigenetic rewiring, biomarkers, and emerging strategies to overcome lapatinib resistance in HER2+ breast cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Howard A. “Skip” Burris, III, MD: An Oncology Pioneer Reflects on Patients, Progress, and Purpose
2
New Bill Makes CMS Enforcer in PBM, Pharmacy Relationship: A Q&A With Jesse Dresser, Esq
3
Asundexian Cuts Recurrent Stroke Risk Without More Bleeding: Mukul Sharma, MD, MSc
4
Faricimab Safe, Effective for Use in Treating nAMD in Treatment-Naive Eyes
5